Seeking Molecular Signatures for Nasopharyngeal Carcinoma

寻找鼻咽癌的分子特征

• 批准号: 351842
• 负责人: Liu Fei-Fei
• 金额: $ 7.29万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-04-01 至 2017-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=351842&lang=en
• 关键词: Biomarkers; Circulating Biomarkers; Distant Metastases; Genomics; Head And Neck Cancer; Micro-Rna; Molecular Signature; Nasopharyngeal Carcinoma; Prognostic Signatures; Translational Medicine

Nasopharyngeal carcinoma (NPC) is a unique cancer of the head & neck region, with a dismal 5-year overall survival rate of approximately 65%. The majority of NPC patients are relatively young (peak incidence between 40-45 years) and are diagnosed with adv

鼻咽癌是头颈部特有的恶性肿瘤，5年生存率低，约为65%。大多数鼻咽癌患者相对年轻（发病高峰期在40-45岁之间），诊断为晚期鼻咽癌。